In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Precision Plus neurostim

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific launches Precision Plus implantable spinal cord stimulator July 2 for treatment of chronic pain in the back, trunk and limbs. A new iteration of the Precision stimulator that debuted in 2005, Precision Plus is the smallest rechargeable spinal cord stimulator available for the indication and features unique EGL Scan technology allowing the physician to position the leads without fluoroscopy or X-ray, the firm says. Boston Scientific got the Precision platform as part of its 2005 acquisition of Advanced Bionics (1"The Gray Sheet" Feb. 7, 2005, p. 4)...

You may also be interested in...

Advanced Bionics Spinal Cord Stimulation Launch Continues With Precision

Boston Scientific's Advanced Bionics unit expects to have a 100-person sales force in place by the end of the third quarter to market its Precision spinal cord stimulation (SCS) system for chronic pain and future indications, including migraine headache

3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.

ACC 2020: Medtronic’s Evolut TAVR Works In Low-Risk Bicuspid Study

Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts